Transasia Bio-Medicals Ltd., India’s Largest Diagnostic Co. acquires a leading European dia

Oct. 6, 2009 - PRLog -- PLIVA Lachema Diagnostika, is engaged in the development, production and marketing of In Vitro Diagnostics products consisting of a range for Urine analysis, Biochemistry and Microbiology. The company, with its extensive marketing and distribution network in the countries of Central and Eastern Europe adequately complements the current market potential and product lines of Transasia and Erba Mannheim. It has state-of-the-art Manufacturing and Research & Development facilities at Brno, employing over 100 people.

The acquisition by Transasia through its German subsidiary ERBA Diagnostics Mannheim GmbH, provides a great opportunity for Transasia and ERBA to usher in newer products in the dynamically developing markets of Asia. Also, Lachema’s customers in Central and Eastern Europe will have access to Transasia’s extensive product range in Clinical Chemistry, Immunoturbidimetry and Immunology. Transasia Bio-Medicals Ltd. and ERBA Diagnostics Mannheim plan to invest more than USD 1 Million in Lachema to increase its manufacturing capacities and add new products in the near future for meeting growing demand. This new acquisition greatly expands the spectrum of technologically advanced products and manufacturing capabilities of Transasia. Transasia and ERBA customers will now benefit with these products being offered at high quality and affordable prices.

This acquisition now allows Transasia customers access to a wide range of solutions for microbiology and usher in a quicker and better diagnosis for a range of health issues, which is great news for the Indian healthcare scene.
This acquisition will augment the company’s vision of bringing benefits of the best diagnostic technologies  within reach for its vast populations in developing countries. The company is a partner of the Clinton foundations Aids control Program in Africa and India.

TRANSASIA and its 100% German subsidiary, ERBA Diagnostics Mannheim GmbH, with its team of experienced marketing and service professionals and an extensive distribution network spread over 55 countries worldwide, in markets like Italy, Germany, France, Australia, China, Turkey, Latin America, Africa, Russia, Middle East, SAARC and Asia are playing a stellar role in bringing world-class products within reach of laboratories across the globe.


With an enviable 30-year track record in the Industry, Transasia Bio-Medicals Ltd. is the largest Indian Manufacturer and Exporter of Diagnostic Instruments and Reagents. The group, founded by Mr. Suresh Vazirani in 1979, provides Total Solutions for Clinical Diagnosis in the field of Biochemistry, Haematology, Immunology, Critical Care, Coagulation, Urine Analysis, Liquid Handling systems and Blood Transfusion medicine.

The Group has a strong tradition of servicing its customers , many of whom are second generation of users and has earned the prestigious CNBC & ICICI Emerging India Award for its impressive 360 degrees approach to business from Research and Development, Manufacturing, Marketing and Service. The coveted “Niryat Shree” for excellence in Exports” has also been received from FIEO, Ministry of Commerce. Manufacturing of instruments and reagents is undertaken at 3 units in India – located at Daman and  Mumbai and Baddi, besides ERBA Mannheim facilities in Germany. All the units of the Group are ISO 9001:2000 & ISO 13485:2003 certified. Transasia Group has the largest Sales and Installation base with over 18,000 installations all over the world supported by a network of 102 service engineers, 58 centres and 14 Zonal offices at metros & major cities. Service support for TRANSASIA equipments and the Infrastructure built to support this has helped to set benchmarks for the industry in terms of service expectations.
______________________________________________________________

# # #

TRANSASIA BIO-MEDICALS LTD. is the leader in the Clinical Diagnostics Segment of the Indian healthcare sector, providing Total Solutions for Clinical Diagnosis.